Robert joined Strata at the start of 2009 and became Managing Partner in 2014. Robert focuses primarily on the software, travel technology & distribution, fintech and IT services sectors. At Strata, he has advised companies such as Adaptive Financial Consulting, Amadeus IT Group, Averroes Capital, Billing Services Group, Branchspace, Company Watch, Dohop, Fits.me, Intelligent Reach, intuitive, Joyful, Luxoft, NVM Private Equity, Pure360, Quintel, Roomex, Sage, SEP (Scottish Equity Partners), thetrainline.com, Warburg Pincus and WorldOne on buy side transactions, sell side transactions, disposals and capital raises. Prior to Strata, from 1996 to 2008, Robert acted on a variety of buy side and sell side M&A transactions, LBOs, privatisations, and IPOs and other equity capital markets transactions at Barclays de Zoete Wedd, Robert Fleming & Co, Dresdner Kleinwort and Credit Suisse. During that time, his technology clients included Amadeus IT Group, Electronic Data Systems, Hellman & Friedman, Misys, PayPoint, Robert Bosch, Staffware and Vista Equity. Robert studied Philosophy, Politics and Economics (PPE) at Oxford University. He speaks English, French and German and has lived and worked in Austria, France, Germany, Italy, the UK and the US.

Mark co-founded Strata in 2002. Mark began his career with Coopers & Lybrand where he qualified as a Chartered Accountant. In 1997, Mark joined Robert Fleming & Co. (now part of JPMorgan) as an investment banker where he was involved in the execution of a wide variety of transactions with an emphasis on public and private M&A and capital raising transactions in the UK mid-market. Mark has an impressive track record in trade sales by way of competitive auction process and the execution of acquisition-led growth strategies. He has particular expertise in the laboratory testing, life science and outsourced research services sectors where he has acted on numerous buy side and sell side transactions. Mark’s clients have included private equity firms such as Bridgepoint Development Capital, CBPE Capital, Inflexion, Limerston and Maven, corporates such as Capita, Eurofins Scientific, Fera Science, LGC, Macquarie Capital, Normec and Pharmaron, and founder-owned businesses such as Crawford Scientific, CgMs, Forensic Access, Melbourn Scientific, M-Scan, SVA and Simbec Research. Mark graduated from Pembroke College, Cambridge University in 1992 with an MA degree in Economics.

Alistair has been with Strata since early 2008 and focuses on all aspects of M&A and growth capital raising transactions. During this time Alistair has worked on buyside and sellside M&A including transactions in healthcare software, fin-tech, mar-tech and small business software. On the buyside, Alistair has worked on long-term engagements with mid-sized and multinational corporations seeking to grow through domestic and cross border acquisitions. For sellside and capital raising transactions, Alistair works closely with companies with recurring or highly repeatable revenue streams to extract and present key metrics and growth drivers. Alistair has completed over 20 transactions at Strata including in healthcare software (five acquisitions by Allocate Software while AiM listed), mar-tech (sale of SEP backed Pure360 to Spotler), fin-tech (sale of SpeedInvest backed Holvi to BBVA), and small business software (sale of HgCapital backed debitoor to SumUp). Prior to joining Strata, Alistair obtained his PhD in Condensed Matter Physics from McGill University in Montreal as a Commonwealth Scholar.